Vanguard Intermediate-Term Bond ETF
Not enough financial coverage to compute a composite score for BIV. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companyinvestor.vanguard.com/investment-products/etfs/profile/biv
Seeks to track the investment return of the Bloomberg U. S. 5–10 Year Government/Credit Float Adjusted Index, a market-weighted bond index that covers investment-grade bonds with a dollar-weighted average maturity of 5 to 10 years.
- IPO
- 2007
- HQ
- Malvern, PA, US
Price Chart
Valuation
- Market Cap
- $51.88B
- Div Yield
- 4.21%
Performance & Tape
- 52W High
- $79.09
- 52W Low
- $75.28
- 50D MA
- $77.01
- 200D MA
- $77.81
- Beta
- 1.03
- Avg Volume
- 2.06M
Get TickerSpark's AI analysis on BIV
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 13, 04 | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP | other | 750,000 |
| Dec 13, 04 | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP | other | 1,500,000 |
| Dec 13, 04 | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP | other | 1,500,000 |
| Jun 21, 06 | Dunker Kristen Marie | other | 55,000 |
| May 13, 04 | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP | buy | 375,044 |
| May 13, 04 | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP | buy | 75,009 |
Our BIV Coverage
We haven't published any research on BIV yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BIV Report →